Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-27T03:32:01.592Z Has data issue: false hasContentIssue false

Associations between food groups and biomarkers of inflammation: Are some foods groups more protective than others?

Published online by Cambridge University Press:  07 May 2024

C. English
Affiliation:
Bond University, Faculty of Health Sciences and Medicine, Bond University; Robina, Queensland Australia
M. Jones
Affiliation:
Institute of Evidence-Based Healthcare, Faculty of Health Sciences and Medicine, Bond University; Robina, Queensland Australia
A. Lohning
Affiliation:
Bond University, Faculty of Health Sciences and Medicine, Bond University; Robina, Queensland Australia
H. Mayr
Affiliation:
Bond University, Faculty of Health Sciences and Medicine, Bond University; Robina, Queensland Australia
H. MacLaughlin
Affiliation:
Queensland University of Technology, School of Exercise and Nutrition Sciences, Faculty of Health, Brisbane, Australia
D. Reidlinger
Affiliation:
Bond University, Faculty of Health Sciences and Medicine, Bond University; Robina, Queensland Australia
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The consumption of healthy foods such as whole grains, vegetables, fruits, nuts, legumes, dairy, and fish is associated with decreased risk of cardiovascular disease (CVD). CVD is an inflammatory disease caused by atherosclerosis. Inflammation is measured clinically using hsCRP, however hsCRP is not specific to CVD. Novel pro-inflammatory markers, such as platelet-activating factor (PAF) and lipoprotein-associated phospholipase A2 (Lp-PLA2), have garnered attention due to their specific roles in endothelial dysfunction and CVD risk. During the COVID 19 outbreak research highlighted a potential interaction between PAF and Lp-PLA2 and the SARS COVID 19 virus(1-3) and related adenovirus-vector and mRNA vaccines.4 This cross-sectional study investigated the association between PAF, Lp-PLA2, hsCRP, and intake of healthy food groups including fruit, cruciferous and other vegetables, grains, meat and poultry, fish and seafood, nuts and legumes, and dairy in 100 adults (49 ± 13 years, 31% male) with variable CVD risk. Data were collected across four groups during May and July 2021 (Groups 1 and 2 - CVD risk factors) and January and April 2022 (Groups 3 and 4 - no CVD risk factors). Fasting PAF, Lp-PLA2 and hsCRP and usual dietary intake (food frequency questionnaire) were measured. Food intake was converted into serves and classified into food groups. Correlations and multiple regressions were performed. Contrary to expectations, mean PAF was lower for groups 1 and 2 (n = 46, mean PAF 3.31 ± 1.66 ng/mL) compared to groups 3 and 4 (n = 54, mean PAF 19.82 ± 12.95 ng/mL) p < 0.001 with a large effect size (eta squared 0.665). Cruciferous vegetables were associated with lower levels of PAF (β = -.27, CI [−0.41, −0.14], p < .001) with a one serve increase in cruciferous vegetables per day associated with an 24% reduction in PAF. Nuts and legumes were associated with lower levels of hsCRP (β = -.51, CI [−0.81, −0.22], p<.001) with an increase of one serve per day associated with a 40% reduction in hsCRP. There were small inverse associations between cheese and both PAF (β = -.15, CI [−0.27, −0.03], p = .017) and Lp-PLA2 (β = -.26, CI [−0.47, −0.04], p = .024), however these were not significant at the Bonferroni-adjusted P<.005 level. In conclusion, cruciferous vegetables and nut and legume consumption were associated with lower levels of inflammation. The lack of associations between PAF and Lp-PLA2 and other healthy foods may be due to confounding by COVID-19 infection and vaccination programs which prevents any firm conclusion on the relationship between PAF, Lp-PLA2 and food groups. Future research should aim to examine the relationship with these novel markers and healthy food groups in a non-pandemic setting.

Type
Abstract
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of The Nutrition Society

References

Antonopoulou, S, Petsini, F, Detopoulou, M et al. (2022) Biofactors 113.Google Scholar
Dua, P, Mishra, A & Reeta KH (2022) Biomark Med 16(10), 821–32.CrossRefGoogle Scholar
English, CJ, Lohning, AE, Mayr, HL et al. (2023) Biofactors 49(2), 457471.CrossRefGoogle Scholar
Ostrowski, SR, Søgaard, OS, Tolstrup, M et al. (2021) Front Immunol 12, 779453.CrossRefGoogle Scholar